Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Qizhi Xiangfu Wan is a traditional Chinese medicine (TCM) product developed and manufactured by Liaoning Jindan Pharmaceutical. It is a multi-herb formulation primarily centered on *Rhizoma Cyperi* (Xiangfu) that has been traditionally processed using seven different adjuncts (typically rice vinegar, wine, ginger juice, honey, salt water, etc.) to enhance its therapeutic efficacy. The formulation is traditionally used to regulate Qi, alleviate depression, and harmonize menstruation. It is indicated for the treatment of irregular menstruation, dysmenorrhea, and abdominal pain caused by Qi stagnation and blood stasis. As a complex TCM formulation, its therapeutic effects are derived from the synergistic action of various phytochemicals on the endocrine and reproductive systems, though specific molecular targets are not typically defined in modern pharmacological terms.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on qizhi xiangfu wan.